Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Public ClinicalTrials.gov record NCT00265330. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
26-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and tolerability of ziprasidone during long-term open-label administration in children and adolescents (ages 10-17) with bipolar I disorder (manic or mixed)
Study identification
- NCT ID
- NCT00265330
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 169 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Jan 2008 (Actual)
- Completion
- Jan 2008 (Actual)
- Last update posted
- Mar 25, 2021
2006 – 2008
United States locations
- U.S. sites
- 41
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Scottsdale | Arizona | 85251 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80045 | — |
| Pfizer Investigational Site | Altamonte Springs | Florida | 32701 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33301 | — |
| Pfizer Investigational Site | North Miami | Florida | 33161 | — |
| Pfizer Investigational Site | Orange City | Florida | 32763 | — |
| Pfizer Investigational Site | Tavares | Florida | 32778 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Honolulu | Hawaii | 96826 | — |
| Pfizer Investigational Site | Terre Haute | Indiana | 47802 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40509 | — |
| Pfizer Investigational Site | Owensboro | Kentucky | 42301 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71103 | — |
| Pfizer Investigational Site | Clinton Township | Michigan | 48038 | — |
| Pfizer Investigational Site | Meridian | Mississippi | 39301 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63044-2588 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68510 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68131 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Pfizer Investigational Site | Rochester | New York | 14618 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45224 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45229 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0559 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44106-5080 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73101 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73107 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73116 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74114 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29405 | — |
| Pfizer Investigational Site | Arlington | Texas | 76011 | — |
| Pfizer Investigational Site | DeSoto | Texas | 75115 | — |
| Pfizer Investigational Site | Lake Jackson | Texas | 77566 | — |
| Pfizer Investigational Site | Plano | Texas | 75093 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Kirkland | Washington | 98033 | — |
| Pfizer Investigational Site | Spokane | Washington | 99204 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53226 | — |
| Pfizer Investigational Site | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00265330, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 25, 2021 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00265330 live on ClinicalTrials.gov.